hero video poster
logo
Site Logo

Dr. Jim Udelson, Dr. Sanjiv Shah, and Dr. C. Michael Gibson Discuss: The take home lessons from the RELIEVE HF study and the path forward (April 25, 2024)

25 April 2024
< Back to News
Share article.

More News

14 January 2025

Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program

7 January 2025

Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population

HomeHeart Failure & Shunt TherapyHealthcare Professionals

Developing therapies for heart failure.

Alleviant Medical, Inc.

7801 N Lamar Blvd

Suite D-106

Austin, TX 78752 USA

info@alleviantmedical.com

https://www.linkedin.com/company/alleviant-medical/https://x.com/allevianthttps://www.facebook.com/alleviantmedical

CAUTION

The Alleviant (ALV1) System is an Investigational Device and is limited by federal (or US) law to investigational use. Exclusively for clinical investigation. The Alleviant (ALV1) System is not cleared, authorized or approved for commercial use in any global geography.

    Site by Show + Tell
  • Privacy Policy
  • Patents
© 2025. Alleviant Medical. All rights reserved. FCOI Policy

CAUTION - Investigational device - Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.